arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

INCYTE CORP

INCY
$120.60 ▲ +2.21 (+1.87%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
67 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
86
Health
Excellent
Bullish
auto_awesome

Analytical Summary

INCYTE CORP shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $24.0B
Dividend Yield
Revenue Growth 20.9%
Op. Margin 23.7%
ROIC 4.7%
FCF / Share $1.85
Trailing P/E 79.3x
Price / Book 4.3x
FCF Yield 1.5%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.27B
↑ +20.9%
Net Income Profit after all expenses
$303.33M
↑ +91.7%
Operating Margin Operating profit as % of sales
23.7%
↑ +6.2% 86th
FCF / Share Free cash flow per share
$1.85
↑ +34.9%
Long-Term Debt Long-term obligations
$420.00M
↑ +43.1%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
88
Returns
90
Cash Quality
69

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters